Vectura fertin pharma, inc., a subsidiary of philip morris international, announces agreement for sale of vectura group to molex

Stamford, ct--(business wire)--vectura fertin pharma, inc., an affiliate of philip morris international inc. (pmi) (nyse: pm), today announces the sale of its subsidiary vectura group ltd. (vectura) to molex asia holdings ltd., and the establishment of master service agreements to develop vectura fertin pharma's inhaled therapeutics proprietary pipeline. vectura will be operated by phillips medisize, a molex company. the sale includes upfront cash consideration of gbp 150 million, subject to cu.
PM Ratings Summary
PM Quant Ranking